Peptide Synthesis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Peptide Synthesis Market Report is Segmented by Technology (Solid-Phase, Liquid-Phase, and Hybrid and Recombinant), Product (Equipment, Reagents and Consumables (Enzymes and Others), and Services), End User (Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Organizations (CDMO), and Academic and Research Institutes), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa). The Report Offers Market Sizes and Forecasts for all the Above Segments in Value (USD).

INSTANT ACCESS

Peptide Synthesis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Peptide Synthesis Market Size

Peptide Synthesis Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 0.95 Billion
Market Size (2030) USD 1.29 Billion
CAGR (2025 - 2030) 6.35 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Peptide Synthesis Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Peptide Synthesis Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Peptide Synthesis Market Analysis

The Global Peptide Synthesis Market size is estimated at USD 0.95 billion in 2025, and is expected to reach USD 1.29 billion by 2030, at a CAGR of 6.35% during the forecast period (2025-2030).

Rising investments and substantial funding for genomics and proteomics research are driving the demand for peptides in drug discovery and therapeutic development. Owing to the rising demand for effective protein-based drugs for the proper treatment process, increasing investments, and significant funding for the research and development of genomics and proteomics in the biopharmaceutical industry, the market is expected to grow during the forecast period.

The increasing government funding to support research and developmental activities and drug discovery is expected to boost the growth of the market, as these investments drive the demand for peptides in genomics and proteomics research. According to the article published by the Department of Health and Aged Care, Australia, in March 2022, the Australian government invested USD 28.1 million from 2022-23 to 2025-26 to establish a new agency, Genomics Australia, to support the integration of genomic medicine as a standard of healthcare in Australia. Such investments by governments are also expected to propel market growth.

There is a rising demand for peptide synthesis as it is useful for proteomics-based biomarker discovery and validation on specific diseases, which is anticipated to boost the market’s growth. For instance, according to an article published by Nature Journal in June 2023, the preference for the PepQuant library over high-resolution mass spectrometry for human blood biomarker discovery expanded the utilization of peptide libraries. This contributes to the increasing research and developments concerning disease therapeutics that use peptides, thus contributing to the market's growth.

Advancements in peptide synthesizer technology, such as microwave-assisted SPPS (solid phase peptide synthesis), have significantly enhanced peptide production. These innovations offer faster synthesis times, increased automation, improved quality, greater scalability, real-time monitoring, and reduced solvent usage. These innovations can accelerate the development of new peptide-based therapeutics, making peptide synthesis more efficient and cost-effective.

The rising benefits of peptide synthesizers, such as their high efficiency and scalability, are anticipated to boost market growth. For instance, according to the study published in Nature Communications in December 2023, peptide synthesis was executed using a Liberty PRIME 2.0 automated microwave peptide synthesizer at a 0.1 mmol scale, incorporating one-pot coupling and deprotection steps. This peptide synthesizer resulted in a highly efficient, pure, and scalable process, reducing waste by up to 95% and requiring only 10-15% of the standard base amount. Therefore, the advantages of effectively conserving solvents with advanced peptide synthesizers are anticipated to increase the adoption of innovative equipment and drive market growth.

However, large-scale synthesis often encounters scalability issues, leading to production challenges and increased costs. Large-scale peptide synthesis demands huge capital, equipment, and skilled labor. A lack of skilled workforce can become a challenge and, hence, limit the growth of the market.

Peptide Synthesis Industry Overview

The peptide synthesis market is competitive in nature, with several major players. Some companies are expanding their market position by adopting various strategies, such as acquisitions, mergers, and research collaborations, while others are introducing new products to maintain their market share. Some of the key market players include Bachem, Merck KGaA, Novozymes, and Thermos Fisher.

Peptide Synthesis Market Leaders

  1. Merck KGaA

  2. Thermo Fisher Scientific Inc.

  3. GenScript

  4. Novozymes A/S

  5. Bachem Holding AG

  6. *Disclaimer: Major Players sorted in no particular order
Peptide Synthesis Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Peptide Synthesis Market News

  • June 2024: Eli Lilly achieved a significant milestone by completing its state-of-the-art synthetic peptide manufacturing facility at its Kinsale, Ireland, site. This facility earned recognition as a 2024 ISPE Facility of the Year Award (FOYA) Category Winner for Innovation. The new IE2b facility exemplifies innovation and safety with its advanced hybrid LPPS/SPPS manufacturing platform.
  • December 2023: Gyros Protein Technologies AB partnered with Biotage, a global provider of high-quality purification and sample preparation solutions. This collaboration introduced Biotage PeptiPEC high-throughput kits, facilitating fast and low solvent consumption solutions for plate-based peptide purification.

Global Peptide Synthesis Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Investments Along with Huge Funding for R&D of Genomics and Proteomics in Bio-pharmaceutical Industry
    • 4.2.2 Rapid Technological Advancements in Peptide Synthesizers and Strong Peptide Therapeutics Pipeline
  • 4.3 Market Restraints
    • 4.3.1 Issues Pertaining to Large-scale Peptide Synthesis and Lack of Robust Distribution Network
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Technique
    • 5.1.1 Solid-phase
    • 5.1.2 Liquid-phase
    • 5.1.3 Hybrid and Recombinant
  • 5.2 By Product Type
    • 5.2.1 Equipment
    • 5.2.2 Reagents and Consumables
    • 5.2.2.1 Enzymes
    • 5.2.2.2 Others
    • 5.2.3 Services
  • 5.3 By End User
    • 5.3.1 Pharmaceutical and Biotechnology Companies
    • 5.3.2 Contract Development and Manufacturing Organization (CDMO)
    • 5.3.3 Academic and Research Institutes
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AAPPTec
    • 6.1.2 AnaSpec
    • 6.1.3 Bachem Holding AG
    • 6.1.4 CEM Corporation
    • 6.1.5 CSBio Company Inc.
    • 6.1.6 Biosynth (Vivitide)
    • 6.1.7 Thermo Fisher Scientific Inc.
    • 6.1.8 GenScript
    • 6.1.9 JPT Peptide Technologies
    • 6.1.10 ProteoGenix
    • 6.1.11 Novozymes A/S (Novonesis Group)
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Peptide Synthesis Industry Segmentation

Peptides are a unique class of highly active and specific pharmaceutical compounds, molecularly poised between small molecules and proteins yet biochemically and therapeutically diverse from both. The advantages of peptides, such as relative ease of synthesis, ready availability, and low toxicity, increased their applications in the pharmaceutical, nutritional, and cosmetic industries, resulting in high demand for rapid advancements in the technologies to enhance their synthesis.

The peptide synthesis market is segmented by technology, product, end user, and geography. By technology, the market is segmented into solid-phase, liquid-phase, and hybrid and recombinant. By product, the market is segmented into equipment, reagents and consumables, and services. The reagents and consumables are further segmented into enzymes and others. By end user, the market is segmented into pharmaceutical and biotechnology companies, contract development and manufacturing organizations (CDMO), and academic and research institutes. By geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The report also covers the market sizes and forecasts in 21 countries across major regions. For each segment, the market sizing and forecasts were made on the basis of revenue (USD).

By Technique Solid-phase
Liquid-phase
Hybrid and Recombinant
By Product Type Equipment
Reagents and Consumables Enzymes
Others
Services
By End User Pharmaceutical and Biotechnology Companies
Contract Development and Manufacturing Organization (CDMO)
Academic and Research Institutes
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Global Peptide Synthesis Market Research Faqs

How big is the Global Peptide Synthesis Market?

The Global Peptide Synthesis Market size is expected to reach USD 0.95 billion in 2025 and grow at a CAGR of 6.35% to reach USD 1.29 billion by 2030.

What is the current Global Peptide Synthesis Market size?

In 2025, the Global Peptide Synthesis Market size is expected to reach USD 0.95 billion.

Who are the key players in Global Peptide Synthesis Market?

Merck KGaA, Thermo Fisher Scientific Inc., GenScript, Novozymes A/S and Bachem Holding AG are the major companies operating in the Global Peptide Synthesis Market.

Which is the fastest growing region in Global Peptide Synthesis Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Peptide Synthesis Market?

In 2025, the North America accounts for the largest market share in Global Peptide Synthesis Market.

What years does this Global Peptide Synthesis Market cover, and what was the market size in 2024?

In 2024, the Global Peptide Synthesis Market size was estimated at USD 0.89 billion. The report covers the Global Peptide Synthesis Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Peptide Synthesis Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Peptide Synthesis Industry Report

Statistics for the 2025 Global Peptide Synthesis market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Peptide Synthesis analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.